Disturbance of pubertal development after cancer treatment

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 16, Issue 1, 2002, Pages 91-103

  Müller, Jørn ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Cancer; Chemotherapy; Puberty; Radiotherapy

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; GROWTH HORMONE; LUTEINIZING HORMONE; PROCARBAZINE; SEX HORMONE; GONADORELIN; SOMATOMEDIN C;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; AZOOSPERMIA; BONE MARROW TRANSPLANTATION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; DELAYED PUBERTY; DISEASE CONTROL; DRUG DOSE REGIMEN; DRUG MEGADOSE; ENDOCRINE DISEASE; FEMALE; GERM CELL; GONADAL DISEASE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LOW DRUG DOSE; MALE; NEPHROBLASTOMA; OVARY DISEASE; PRECOCIOUS PUBERTY; PREDICTION; PROGNOSIS; PUBERTY; PUBERTY DISORDERS; REVIEW; SEX DIFFERENCE; SIDE EFFECT; SKULL IRRADIATION; SOLID TUMOR; SPERMATOGENESIS; TESTIS DISEASE; WHOLE BODY RADIATION; CANCER SURGERY; CANCER THERAPY; GONAD DYSFUNCTION; HORMONE SUBSTITUTION; MENARCHE; OVARY INSUFFICIENCY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION STERILIZATION; REPRODUCTIVE TOXICITY; SEXUAL MATURATION; TESTIS SIZE;

EID: 0036429858     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2002.0183     Document Type: Article

References (44)

1. Anonymous. Cancer in Children - Clinical Management. Oxford: Oxford University Press, 1998.
2. DeVile CJ, Grant DB, Hayward RD & Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Archives of Disease in Childhood 1996; 75: 108-114.
3. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Medical and Pediatric Oncology 1999; 33: 2-8.
4. Meistrich ML, Wilson G, Brown BW et al. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 1992; 70: 2703-2712.
5. Leiper AD, Stanhope R, Kirching P & Chessels JM. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Archives of Disease in Childhood 1987; 62: 1107-1112.
6. Didcock E, Davies HA, Didi M et al. Pubertal growth in young adult survivors of childhood leukemia. Journal of Clinical Oncology 1995; 13: 2503-2507.
7. Groot-Loonen JJ, van Setten P, Otten BJ et al. Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia. Acta Paediatrica 1996; 85: 1091-1095.
8. Hokken-Koelega ACS, van Doorn WD, Hählen K et al. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty; a comparative study. Pediatric Research 1993; 33: 577-582.
9. Melin AE, Adan L, Leverger G et al. Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemia. European Journal of Pediatrics 1998; 157: 703-707.
10. Moëll C, Marky I, Hovi L et al. Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Medical and Pediatric Oncology 1994; 22: 375-379.
11. Moell C, Garwicz S, Westgren U & Wiebe T. Disturbed pubertal growth in girls treated for acute lymphoblastic leukemia. Pediatric Hematology and Oncology 1987; 4: 1-5.
12. Mohnike K, Dorffel, W, Timme J et al. Final height and puberty in 40 patients after antileukaemic treatment during childhood. European Journal of Pediatrics 1997; 156: 272-276.
13. Maneschi F, Fugardi MG, Corsello G & LoCurto M. Pubertal maturation in girls treated for childhood acute leukaemia. European Journal of Pediatrics 1991; 150: 630-633.
14. Stubberfield TG, Byrne GC & Jones TW. Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation. Journal of Pediatric Hematology Oncology 1995; 17: 167-171.
15. Noorda EM, Somers R, van Leeuwen FE et al. Adult height and age at menarche in childhood cancer survivors. European Journal of Cancer 2001; 37: 605-612.
16. Mills JL, Fears TR, Robison LL et al. Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukaemia. Journal of Pediatrics 1997; 131: 598-602.
17. Holm K, Nysom K, Hertz H & Müller J. Normal final height after treatment for acute lymphoblastical leukemia without irradiation. Acta Paediatrica Scandinavica 1994; 83: 1287-1290.
18. Schmiegelow M, Hertz H, & Müller J. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 during maintenance chemotherapy of acute lymphoblastic leukemia in children. Journal of Pediatric Hematology Oncology 1999; 21: 268-273.
19. Bakker B, Massa GG, Oostdijk W et al. Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. European Journal of Pediatrics 2000; 159: 31-37.
20. Sarafoglou K, Boulad F, Gillio A & Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. Journal of Pediatrics 1997; 130: 210-216.
21. Clement-De BA, Oostdijk W, Van Weel-Sipman MH et al. Final height and hormonal function after bone marrow transplantation in children. Journal of Pediatrics 1996; 129: 544-550.
22. Mayer EI, Dopfer RE, Klingebiel T et al. Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatric Transplantation 1999; 3: 38-44.
23. Legault L & Bonny Y. Endocrine complications of bone marrow transplantation in children. Pediatric Transplantation 1999; 3: 60-66.
24. Michel G, Socie G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation - a report from the Société Francaise de Greffe de Moelle. Journal of Clinical Oncology 1997; 15: 2238-2246.
25. Holm K, Nysom K, Brocks V et al. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplantation 1999; 23: 259-263.
26. Hovi L, Tapanainen P, Saarinen-Pihkala UM & Siimes MA. Impaired androgen production in female adolescents and young adults after total body irradiation prior to BMT in childhood. Bone Marrow Transplantation 1997; 20: 561-565.
27. Thibaud E, Rodriguez-Macias K, Trivin C et al. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplantation 1998; 21: 287-290.
28. Chou RH, Wong GB, Kramer JH et al. Toxicities of total-body irradiation for pediatric bone marrow transplantation. International Journal of Radiation, Oncology, Biology, Physics 1996; 34: 843-851.
29. Larse EC, Loft A, Holm K et al. Oocyte donation in women cured with bone marrow transplantation including total body irradiation in adolescence. Human Reproduction 2000; 15: 1505-1508.
30. Collet-Solberg PF, Sernyak H, Satin-Smith M et al. Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Clinical Endocrinology 1997; 47: 79-85.
31. Lannering B, Jansson C, Rosberg S & Albertsson-Wikland K. Increased LH and FSH secretion after cranial irradiation in boys. Medical and Pediatric Oncology 1997; 29: 280-287.
32. Oberfield SE, Chin D, Uli N et al. Endocrine late effects of childhood cancers. Journal of Pediatrics 1997; 131: S37-S41.
33. Oberfield SE, Soranno D, Nirenberg A et al. Age at onset of puberty following high-dose central nervous system radiation therapy. Archives of Pediatrics and Adolescent Medicine 1996; 150: 589-592.
34. Ogilvy-Stuart AL, Clayton PE & Shalet SM. Cranial irradiation and early puberty. Journal of Clinical Endocrinology and Metabolism 1994; 78: 1282-1286.
35. Constine LS, Woolf PD, Cann D et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. New England Journal of Medicine 1993; 328: 87-94.
36. Schmiegelow M, Lassen S, Poulsen HS et al. Gonadal status in male survivors following childhood brain tumors. Journal of Clinical Endocrinology and Metabolism 2001; 86: 2446-2452.
37. Gerres L, Bramswig JH, Schlegel W et al. The effects of etoposide on testicular function in boys treated for Hodgkin's disease. Cancer 1998; 83: 2217-2222.
38. Mackie EJ, Radford M & Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Medical and Pediatric Oncology 1996; 27: 74-78.
39. Papadakis V, Vlachopapadopoulou E, Van Syckle K et al. Gonadal function in young patients successfully treated for Hodgkin disease. Medical and Pediatric Oncology 1999; 32: 366-372.
40. Ben Arush MW, Solt I, Lightman A et al. Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma. Pediatric Hematology and Oncology 2000; 17: 239-245.
41. Paulino AC, Wen BC, Brown CK et al. Late effects in children treated with radiation therapy for Wilms' tumor. International Journal of Radiation, Oncology, Biology, Physics 2000; 46: 1239-1246.
42. Hale GA, Marina NM, Jones-Wallace D et al. Late effects of treatment for germ cell tumors during childhood and adolescence. Journal of Pediatric Hematology and Oncology 1999; 21: 115-122.
43. Adan L, Souberbielle JC, Blanche S et al. Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Acta Paediatrica 1996; 85: 1096-1101.
44. Ogilvy-Stuart AL & Shalet SM. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Archives of Disease in Childhood 1995; 73: 141-146.